11 %The prevalence of parasitemia was 11.0% in the healthy non-SCD controls.
Nigeriapaludismepublished 2024HemoglobinPubMeddocument of 3 observations
Gold tier: mechanically validated evidence, with its primary source.
8,823 evidence items · page 31 / 353
11 %The prevalence of parasitemia was 11.0% in the healthy non-SCD controls.
Nigeriapaludismepublished 2024HemoglobinPubMeddocument of 3 observations
1.17 daysThe mean fever clearance time was 1.17 days in the quinine group.
Nigeriapaludismepublished 1992Annals of Tropical Medicine and ParasitologyOpenAlexdocument of 19 observations
98.9 %After a health education session, 98.9% of pregnant women understood that both parents must have at least one gene for someone to have sickle cell disease, compared to 77.5% before the session.
Nigeriadrépanocytosepublished 2024BMC pregnancy and childbirthPubMeddocument of 6 observations
64.1 %Among 168 people living with HIV (PLHIV) studied, 64.1% had fertility desire.
NigeriaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 5 observations
5.9 %The N86Y haplotype was detected only in 5.9% of cord blood isolates.
Nigeriapaludismepublished 2025PlacentaPubMeddocument of 7 observations
38 %The pooled prevalence of SARS-CoV-2 infection among residents of care homes and patients was 38%.
NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 4 observations
2.01 AORRespondents living with HIV had higher odds for physical violence (AOR: 2.01; 95% CI: 1.46–2.76; p < 0.001).
NigeriaVIH/sidaobserved 2021published 2022BMC public healthPubMeddocument of 12 observations
13.5 %Depression was cited as a reason for antiretroviral therapy non-adherence in 57 cases (13.5%) among female sex workers who died from HIV/AIDS.
NigeriaVIH/sidaobserved 2022-02-01 to 2023-02-28published 2026International journal of environmental research and public healthPubMeddocument of 10 observations
4.2 %Among 119 children with Plasmodium falciparum infection in Lagos, Nigeria, 4.2% had the wild-type pfcrt haplotype (CVMNK).
Nigeriapaludismepublished 2015Diagnostic pathologyeurope_pmcdocument of 5 observations
48.9 yearsThe ages of the breast cancer patients ranged from 26 to 95 years, with a mean age of 48.9 ± 14.9 years and a median age of 47.5 years.
Nigeriacancer du seinobserved 2011–2015published 2020The Pan African medical journalPubMeddocument of 16 observations
3.88 AORLiving with HIV was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 3.88).
NigeriaCOVID-19 · VIH/sidaobserved 2020published 2022Frontiers in public healthPubMeddocument of 10 observations
Hyperparasitaemic children had higher core temperature on presentation compared with non-hyperparasitaemic children.
Nigeriapaludismepublished 2011Asian Pacific Journal of Tropical DiseaseOpenAlexdocument of 13 observations
72.6 %72.6% of participants who owned a mobile phone were willing to receive mobile phone-based diabetes health services.
Nigeriadiabète (non précisé)published 2020The Pan African medical journalPubMeddocument of 12 observations
28 %Among 224 HIV-1 infected samples from 6 Nigerian cities, the subtype distribution was 28% G.
NigeriaVIH/sidapublished 2016MedicinePubMeddocument of 7 observations
72.5 %The overall prevalence of low high-density lipoprotein cholesterol (l-HDL) among 3,211 adult Nigerians was 72.5%.
Nigerialow high-density lipoprotein cholesterolobserved 2017-2018published 2022Cardiovascular journal of AfricaPubMeddocument of 4 observations
309 patientsA total of 309 histologically confirmed de-identified metastatic breast cancer patients were consecutively recruited from the NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Nigeriametastatic breast cancerobserved between September 2020 and February 2022published 2026PloS onePubMeddocument of 7 observations
28.8 %The overall seroprevalence of anti-Toxoplasma gondii IgG was 28.8%.
NigeriaToxoplasma gondii infectionpublished 2020Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument of 8 observations
38.2 %The global prevalence of HIV-associated heart disease ranged from 38.2% to 75.9%.
NigeriaHIV-associated heart diseasepublished 2025The Nigerian postgraduate medical journalPubMeddocument of 10 observations
42 patientsAmong the 257 enrolled sickle cell anaemia patients, 42 had proteinuric chronic kidney disease.
Nigeriadrépanocytose · proteinuric chronic kidney diseaseobserved January 2013 to April 2018published 2021Hematology/oncology and stem cell therapyPubMeddocument of 6 observations
69.5 %The seroprevalence of chikungunya and malaria was 69.5% in the central region of Nigeria.
Nigeriachikungunyapublished 2022International journal of environmental research and public healthPubMeddocument of 6 observations
32.4 %32.4% of the respondents were cervical cancer patients.
Nigeriacancer du col de l'utéruspublished 2026BMC women's healthPubMeddocument of 6 observations
228 casesThere were 228 cases of Epstein-Barr virus (EBV) infection among 1157 diseased patients in the included studies.
NigeriaEpstein-Barr virus (EBV) infectionpublished 2022Indian journal of medical microbiologyPubMeddocument of 8 observations
77.3 %Among Nigerians with pre-diabetes, moderate exercise decreased insulin resistance by 77.3% (HOMA-IR) after 12 weeks of intervention.
Nigeriapre-diabetespublished 2024The Nigerian postgraduate medical journalPubMeddocument of 4 observations
36.91 yearsThe mean age of HIV-infected participants in Port Harcourt was 36.91 years.
NigeriaVIH/sidapublished 2021African health sciencesPubMeddocument of 4 observations
1.7 daysParasite clearance was significantly faster in children treated with artemether-lumefantrine (AL), with a mean of 1.7 days and standard deviation of 0.6 days.
Nigeriapaludismepublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 5 observationsDOI 10.4269/ajtmh.2007.77.235
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.